Skip Page Header

Home > Buprenorphine/Naloxone for opioid dependence: clinical practice guideline.

Handford, Curtis and Kahan, Meldon and Srivastava, Anita and Cirone, Sharon and Palda, Valerie (2011) Buprenorphine/Naloxone for opioid dependence: clinical practice guideline. Toronto: Centre for Addiction and Mental health.

[img]
Preview
PDF (Buprenorphine/Naloxone for opioid dependence) - Published Version
1MB
[img]
Preview
PDF (Drug and Alcohol Findings summary) - Supplemental Material
53kB

• The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
• The guideline intends to contribute to education of practitioners regarding opioid prescribing, improved patient access to treatment for opioid dependence, and safe prescribing and dispensing of buprenorphine/naloxone.
• This evidence-based clinical practice guideline was developed by a multidisciplinary committee, and included specialists in the field of addiction medicine, family medicine and pharmacy.
• A systematic review of the literature formed the evidence base for this guideline, and recommendations were assigned levels of evidence and grades of recommendations based on those developed by the Canadian Task Force on Preventive Health Care.


Repository Staff Only: item control page